S |
2024-06-17 |
2024-06-20 17:01:22.0 |
Intellia Therapeutics, Inc. |
NTLA |
Verwiel Frank |
|
1,505 |
$25.00 |
$37,625.00 |
17,948 |
|
view |
S |
2024-03-04 |
2024-03-05 16:11:13.0 |
Intellia Therapeutics, Inc. |
NTLA |
Clark Eliana |
(EVP, Chief Technical Officer) |
six hundred and five |
$32.99 |
$19,958.90 |
71,470 |
|
view |
S |
2024-03-04 |
2024-03-05 16:11:06.0 |
Intellia Therapeutics, Inc. |
NTLA |
BASTA JAMES |
(EVP, General Counsel) |
2,297 |
$32.99 |
$75,778.00 |
81,571 |
|
view |
S |
2024-01-08 |
2024-01-10 16:15:54.0 |
Intellia Therapeutics, Inc. |
NTLA |
Sepp-Lorenzino Laura |
(EVP, Chief Scientific Officer) |
six hundred and sixty-seven |
$29.38 |
$19,596.50 |
43,927 |
|
view |
S |
2024-01-08 |
2024-01-10 16:15:54.0 |
Intellia Therapeutics, Inc. |
NTLA |
Sepp-Lorenzino Laura |
(EVP, Chief Scientific Officer) |
1,608 |
$28.66 |
$46,085.30 |
44,594 |
|
view |
S |
2024-01-03 |
2024-01-05 16:51:33.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
(President and CEO) |
19,223 |
$29.46 |
$566,310.00 |
846,486 |
|
view |
S |
2024-01-03 |
2024-01-05 16:51:17.0 |
Intellia Therapeutics, Inc. |
NTLA |
Lebwohl David |
(EVP, Chief Medical Officer) |
5,843 |
$29.46 |
$172,135.00 |
54,372 |
|
view |
S |
2024-01-03 |
2024-01-05 16:51:05.0 |
Intellia Therapeutics, Inc. |
NTLA |
Sepp-Lorenzino Laura |
(EVP, Chief Scientific Officer) |
5,532 |
$29.46 |
$162,973.00 |
46,202 |
|
view |
S |
2024-01-03 |
2024-01-05 16:49:45.0 |
Intellia Therapeutics, Inc. |
NTLA |
Goddard Glenn |
(EVP, Chief Financial Officer) |
5,365 |
$29.46 |
$158,053.00 |
40,585 |
|
view |
S |
2024-01-03 |
2024-01-05 16:47:15.0 |
Intellia Therapeutics, Inc. |
NTLA |
Hicks Derek |
(EVP, Chief Business Officer) |
3,877 |
$29.46 |
$114,216.00 |
36,987 |
|
view |
S |
2024-01-03 |
2024-01-05 16:46:08.0 |
Intellia Therapeutics, Inc. |
NTLA |
BASTA JAMES |
(EVP, General Counsel) |
3,805 |
$29.46 |
$112,095.00 |
51,474 |
|
view |
S |
2024-01-03 |
2024-01-05 16:45:31.0 |
Intellia Therapeutics, Inc. |
NTLA |
Clark Eliana |
(EVP, Chief Technical Officer) |
4,301 |
$29.46 |
$126,707.00 |
40,845 |
|
view |
S |
2024-01-03 |
2024-01-05 16:45:31.0 |
Intellia Therapeutics, Inc. |
NTLA |
Clark Eliana |
(EVP, Chief Technical Officer) |
three hundred and seven |
$30.12 |
$9,246.84 |
45,146 |
|
view |
S |
2023-10-31 |
2023-11-02 16:43:47.0 |
Intellia Therapeutics, Inc. |
NTLA |
Bhanji Muna |
director |
two hundred and sixty-five |
$23.90 |
$6,333.50 |
11,996 |
|
view |
S |
2023-07-31 |
2023-08-02 17:20:24.0 |
Intellia Therapeutics, Inc. |
NTLA |
Bhanji Muna |
director |
two hundred and sixty-five |
$42.33 |
$11,217.50 |
12,261 |
|
view |
S |
2023-07-06 |
2023-07-10 17:22:20.0 |
Intellia Therapeutics, Inc. |
NTLA |
Bhanji Muna |
director |
1,867 |
$39.30 |
$73,373.10 |
12,526 |
|
view |
S |
2023-07-03 |
2023-07-06 15:35:12.0 |
Intellia Therapeutics, Inc. |
NTLA |
Clark Eliana |
officer (EVP, Chief Technical Officer) |
three hundred and sixty |
$40.51 |
$14,583.60 |
45,146 |
|
view |
S |
2023-06-20 |
2023-06-22 17:52:48.0 |
Intellia Therapeutics, Inc. |
NTLA |
Clark Eliana |
officer (EVP, Chief Technical Officer) |
5,000 |
$45.00 |
$225,000.00 |
45,146 |
|
view |
S |
2023-03-02 |
2023-03-03 17:11:32.0 |
Intellia Therapeutics, Inc. |
NTLA |
BASTA JAMES |
officer (EVP, General Counsel) |
1,088 |
$43.88 |
$47,741.40 |
55,279 |
|
view |
S |
2023-01-05 |
2023-01-06 17:40:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Sepp-Lorenzino Laura |
officer (EVP, Chief Scientific Officer) |
six hundred and eighty-nine |
$39.10 |
$26,939.90 |
17,629 |
|
view |
S |
2023-01-05 |
2023-01-06 17:40:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Sepp-Lorenzino Laura |
officer (EVP, Chief Scientific Officer) |
1,641 |
$38.22 |
$62,719.00 |
18,318 |
|
view |
S |
2023-01-04 |
2023-01-06 17:40:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Sepp-Lorenzino Laura |
officer (EVP, Chief Scientific Officer) |
2,508 |
$37.21 |
$93,322.70 |
19,959 |
|
view |
S |
2023-01-04 |
2023-01-06 17:34:02.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
6,673 |
$37.21 |
$248,302.00 |
766,825 |
|
view |
S |
2022-01-01 |
2022-03-04 21:07:32.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
2,493 |
$112.25 |
$279,852.00 |
724,660 |
|
view |
S |
2022-01-01 |
2022-03-03 20:04:54.0 |
Intellia Therapeutics, Inc. |
NTLA |
Sepp-Lorenzino Laura |
officer (EVP, Chief Scientific Officer) |
1,148 |
$112.25 |
$128,863.00 |
4,815 |
|
view |
S |
2022-01-01 |
2022-03-03 20:01:00.0 |
Intellia Therapeutics, Inc. |
NTLA |
Lebwohl David |
officer (EVP, Chief Medical Officer) |
1,051 |
$112.24 |
$117,964.00 |
10,922 |
|
view |
S |
2022-01-01 |
2022-03-03 19:38:57.0 |
Intellia Therapeutics, Inc. |
NTLA |
Goddard Glenn |
officer (EVP, Chief Financial Officer) |
1,013 |
$112.24 |
$113,699.00 |
2,049 |
|
view |
S |
2021-11-05 |
2021-11-09 18:11:28.0 |
Intellia Therapeutics, Inc. |
NTLA |
Lebwohl David |
officer (EVP, Chief Medical Officer) |
two hundred |
$135.34 |
$27,068.00 |
8,714 |
|
view |
S |
2021-11-05 |
2021-11-09 18:11:28.0 |
Intellia Therapeutics, Inc. |
NTLA |
Lebwohl David |
officer (EVP, Chief Medical Officer) |
five hundred and forty-eight |
$134.07 |
$73,470.40 |
8,914 |
|
view |
S |
2021-11-05 |
2021-11-09 18:11:28.0 |
Intellia Therapeutics, Inc. |
NTLA |
Lebwohl David |
officer (EVP, Chief Medical Officer) |
four hundred and fifty-two |
$132.62 |
$59,944.20 |
9,462 |
|
view |
S |
2021-11-05 |
2021-11-09 18:11:28.0 |
Intellia Therapeutics, Inc. |
NTLA |
Lebwohl David |
officer (EVP, Chief Medical Officer) |
1,200 |
$131.71 |
$158,052.00 |
9,914 |
|
view |
S |
2021-10-14 |
2021-10-15 19:04:03.0 |
Intellia Therapeutics, Inc. |
NTLA |
Lebwohl David |
officer (EVP, Chief Medical Officer) |
two hundred and fifty |
$130.47 |
$32,617.50 |
8,714 |
|
view |
S |
2021-10-14 |
2021-10-15 19:04:03.0 |
Intellia Therapeutics, Inc. |
NTLA |
Lebwohl David |
officer (EVP, Chief Medical Officer) |
five hundred and twenty-five |
$129.83 |
$68,160.80 |
8,964 |
|
view |
S |
2021-10-14 |
2021-10-15 19:04:03.0 |
Intellia Therapeutics, Inc. |
NTLA |
Lebwohl David |
officer (EVP, Chief Medical Officer) |
two hundred and twenty-five |
$129.01 |
$29,027.20 |
9,489 |
|
view |
S |
2021-10-14 |
2021-10-15 19:04:03.0 |
Intellia Therapeutics, Inc. |
NTLA |
Lebwohl David |
officer (EVP, Chief Medical Officer) |
eight hundred and forty-nine |
$127.81 |
$108,511.00 |
9,714 |
|
view |
S |
2021-10-14 |
2021-10-15 19:04:03.0 |
Intellia Therapeutics, Inc. |
NTLA |
Lebwohl David |
officer (EVP, Chief Medical Officer) |
five hundred and fifty-one |
$126.92 |
$69,932.90 |
10,563 |
|
view |
S |
2021-10-11 |
2021-10-13 16:16:00.0 |
Intellia Therapeutics, Inc. |
NTLA |
Crowley John F |
director |
2,500 |
$119.55 |
$298,875.00 |
2,094 |
|
view |
S |
2021-10-05 |
2021-10-07 17:41:49.0 |
Intellia Therapeutics, Inc. |
NTLA |
Crowley John F |
director |
two hundred |
$132.84 |
$26,568.00 |
2,094 |
|
view |
S |
2021-10-05 |
2021-10-07 17:41:49.0 |
Intellia Therapeutics, Inc. |
NTLA |
Crowley John F |
director |
1,846 |
$131.74 |
$243,192.00 |
2,294 |
|
view |
S |
2021-10-05 |
2021-10-07 17:41:49.0 |
Intellia Therapeutics, Inc. |
NTLA |
Crowley John F |
director |
3,759 |
$130.92 |
$492,128.00 |
4,140 |
|
view |
S |
2021-10-05 |
2021-10-07 17:41:49.0 |
Intellia Therapeutics, Inc. |
NTLA |
Crowley John F |
director |
2,915 |
$129.88 |
$378,600.00 |
7,899 |
|
view |
S |
2021-10-05 |
2021-10-07 17:41:49.0 |
Intellia Therapeutics, Inc. |
NTLA |
Crowley John F |
director |
1,280 |
$128.83 |
$164,902.00 |
10,814 |
|
view |
S |
2021-09-07 |
2021-09-09 17:39:14.0 |
Intellia Therapeutics, Inc. |
NTLA |
Goddard Glenn |
officer (EVP, Chief Financial Officer) |
3,482 |
$180.12 |
$627,178.00 |
zero |
|
view |
S |
2021-08-31 |
2021-09-01 19:34:43.0 |
Intellia Therapeutics, Inc. |
NTLA |
Goddard Glenn |
officer (EVP, Chief Financial Officer) |
24,800 |
$160.22 |
$3,973,460.00 |
zero |
|
view |
S |
2021-08-30 |
2021-09-01 19:34:43.0 |
Intellia Therapeutics, Inc. |
NTLA |
Goddard Glenn |
officer (EVP, Chief Financial Officer) |
three hundred |
$160.84 |
$48,252.00 |
zero |
|
view |
S |
2021-08-30 |
2021-09-01 19:34:43.0 |
Intellia Therapeutics, Inc. |
NTLA |
Goddard Glenn |
officer (EVP, Chief Financial Officer) |
three hundred |
$159.53 |
$47,859.00 |
three hundred |
|
view |
S |
2021-08-30 |
2021-09-01 19:34:43.0 |
Intellia Therapeutics, Inc. |
NTLA |
Goddard Glenn |
officer (EVP, Chief Financial Officer) |
three hundred |
$158.42 |
$47,526.00 |
six hundred |
|
view |
S |
2021-08-30 |
2021-09-01 19:34:43.0 |
Intellia Therapeutics, Inc. |
NTLA |
Goddard Glenn |
officer (EVP, Chief Financial Officer) |
four hundred and ninety-six |
$157.33 |
$78,035.70 |
nine hundred |
|
view |
S |
2021-08-30 |
2021-09-01 19:34:43.0 |
Intellia Therapeutics, Inc. |
NTLA |
Goddard Glenn |
officer (EVP, Chief Financial Officer) |
three hundred |
$156.10 |
$46,830.00 |
1,396 |
|
view |
S |
2021-08-30 |
2021-09-01 19:34:43.0 |
Intellia Therapeutics, Inc. |
NTLA |
Goddard Glenn |
officer (EVP, Chief Financial Officer) |
1,700 |
$155.29 |
$263,993.00 |
1,696 |
|
view |
S |
2021-08-30 |
2021-09-01 19:34:43.0 |
Intellia Therapeutics, Inc. |
NTLA |
Goddard Glenn |
officer (EVP, Chief Financial Officer) |
1,100 |
$154.29 |
$169,719.00 |
3,396 |
|
view |
S |
2021-08-30 |
2021-09-01 19:34:43.0 |
Intellia Therapeutics, Inc. |
NTLA |
Goddard Glenn |
officer (EVP, Chief Financial Officer) |
seven hundred and four |
$153.22 |
$107,867.00 |
4,496 |
|
view |
S |
2021-08-30 |
2021-09-01 19:34:43.0 |
Intellia Therapeutics, Inc. |
NTLA |
Lebwohl David |
officer (EVP, Chief Medical Officer) |
one hundred and fifty |
$160.10 |
$24,015.00 |
seven hundred and ninety-one |
|
view |
S |
2021-08-30 |
2021-09-01 19:34:43.0 |
Intellia Therapeutics, Inc. |
NTLA |
Lebwohl David |
officer (EVP, Chief Medical Officer) |
1,100 |
$159.19 |
$175,109.00 |
nine hundred and forty-one |
|
view |
S |
2021-08-30 |
2021-09-01 19:34:43.0 |
Intellia Therapeutics, Inc. |
NTLA |
Lebwohl David |
officer (EVP, Chief Medical Officer) |
two hundred and fifty |
$157.60 |
$39,400.00 |
2,041 |
|
view |
S |
2021-08-30 |
2021-09-01 19:34:43.0 |
Intellia Therapeutics, Inc. |
NTLA |
Lebwohl David |
officer (EVP, Chief Medical Officer) |
seven hundred |
$156.70 |
$109,690.00 |
2,291 |
|
view |
S |
2021-08-30 |
2021-09-01 19:34:43.0 |
Intellia Therapeutics, Inc. |
NTLA |
Lebwohl David |
officer (EVP, Chief Medical Officer) |
two hundred |
$155.43 |
$31,086.00 |
2,991 |
|
view |
S |
2021-08-23 |
2021-08-25 16:15:00.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
one hundred |
$153.52 |
$15,352.00 |
719,305 |
|
view |
S |
2021-08-23 |
2021-08-25 16:15:00.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
8,165 |
$153.08 |
$1,249,900.00 |
719,405 |
|
view |
S |
2021-08-23 |
2021-08-25 16:15:00.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
18,874 |
$151.54 |
$2,860,170.00 |
727,570 |
|
view |
S |
2021-08-09 |
2021-08-11 16:51:35.0 |
Intellia Therapeutics, Inc. |
NTLA |
Lebwohl David |
officer (EVP, Chief Medical Officer) |
2,400 |
$164.05 |
$393,720.00 |
seven hundred and ninety-one |
|
view |
S |
2021-08-04 |
2021-08-06 18:20:12.0 |
Intellia Therapeutics, Inc. |
NTLA |
Sepp-Lorenzino Laura |
officer (EVP, Chief Scientific Officer) |
one hundred and twenty-six |
$141.63 |
$17,845.40 |
2,391 |
|
view |
S |
2021-08-04 |
2021-08-06 18:20:12.0 |
Intellia Therapeutics, Inc. |
NTLA |
Sepp-Lorenzino Laura |
officer (EVP, Chief Scientific Officer) |
4,054 |
$140.73 |
$570,519.00 |
2,517 |
|
view |
S |
2021-08-04 |
2021-08-06 18:20:12.0 |
Intellia Therapeutics, Inc. |
NTLA |
Sepp-Lorenzino Laura |
officer (EVP, Chief Scientific Officer) |
2,772 |
$139.85 |
$387,664.00 |
6,571 |
|
view |
S |
2021-08-04 |
2021-08-06 18:20:12.0 |
Intellia Therapeutics, Inc. |
NTLA |
Sepp-Lorenzino Laura |
officer (EVP, Chief Scientific Officer) |
4,419 |
$138.78 |
$613,269.00 |
9,343 |
|
view |
S |
2021-08-04 |
2021-08-06 18:20:12.0 |
Intellia Therapeutics, Inc. |
NTLA |
Sepp-Lorenzino Laura |
officer (EVP, Chief Scientific Officer) |
6,344 |
$137.72 |
$873,696.00 |
13,762 |
|
view |
S |
2021-08-04 |
2021-08-06 18:20:12.0 |
Intellia Therapeutics, Inc. |
NTLA |
Sepp-Lorenzino Laura |
officer (EVP, Chief Scientific Officer) |
6,814 |
$136.79 |
$932,087.00 |
20,106 |
|
view |
S |
2021-08-04 |
2021-08-06 18:20:12.0 |
Intellia Therapeutics, Inc. |
NTLA |
Sepp-Lorenzino Laura |
officer (EVP, Chief Scientific Officer) |
1,471 |
$135.47 |
$199,276.00 |
26,920 |
|
view |
S |
2021-06-28 |
2021-06-29 09:49:07.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
6,149 |
$143.45 |
$882,074.00 |
10,000 |
|
view |
S |
2021-06-28 |
2021-06-29 09:49:07.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
13,556 |
$142.88 |
$1,936,880.00 |
16,149 |
|
view |
S |
2021-06-28 |
2021-06-29 09:49:07.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
8,420 |
$141.66 |
$1,192,780.00 |
29,705 |
|
view |
S |
2021-06-28 |
2021-06-29 09:49:07.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
8,027 |
$140.80 |
$1,130,200.00 |
38,125 |
|
view |
S |
2021-06-28 |
2021-06-29 09:49:07.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
52,320 |
$139.96 |
$7,322,710.00 |
46,152 |
|
view |
S |
2021-06-28 |
2021-06-29 09:49:07.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
4,201 |
$138.58 |
$582,175.00 |
98,472 |
|
view |
S |
2021-06-28 |
2021-06-29 09:49:07.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
5,400 |
$138.05 |
$745,470.00 |
102,673 |
|
view |
S |
2021-06-28 |
2021-06-29 09:49:07.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
3,033 |
$137.01 |
$415,551.00 |
108,073 |
|
view |
S |
2021-06-28 |
2021-06-29 09:49:07.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
21,893 |
$135.83 |
$2,973,730.00 |
111,106 |
|
view |
S |
2021-06-28 |
2021-06-29 09:49:07.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
30,831 |
$134.86 |
$4,157,870.00 |
132,999 |
|
view |
S |
2021-06-28 |
2021-06-29 09:49:07.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
36,519 |
$133.77 |
$4,885,150.00 |
163,830 |
|
view |
S |
2021-06-28 |
2021-06-29 09:49:07.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
56,188 |
$132.77 |
$7,460,080.00 |
200,349 |
|
view |
S |
2021-06-28 |
2021-06-29 09:49:07.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
53,823 |
$131.82 |
$7,094,950.00 |
256,537 |
|
view |
S |
2021-06-28 |
2021-06-29 09:49:07.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
66,468 |
$130.79 |
$8,693,350.00 |
310,360 |
|
view |
S |
2021-06-28 |
2021-06-29 09:49:07.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
48,724 |
$129.88 |
$6,328,270.00 |
376,828 |
|
view |
S |
2021-06-28 |
2021-06-29 09:49:07.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
56,280 |
$128.77 |
$7,247,180.00 |
425,552 |
|
view |
S |
2021-06-28 |
2021-06-29 09:49:07.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
55,525 |
$127.79 |
$7,095,540.00 |
481,832 |
|
view |
S |
2021-06-28 |
2021-06-29 09:49:07.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
26,019 |
$127.02 |
$3,304,930.00 |
537,357 |
|
view |
S |
2021-06-14 |
2021-06-15 09:52:57.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
six hundred and fifty-three |
$89.25 |
$58,280.20 |
563,376 |
|
view |
S |
2021-06-14 |
2021-06-15 09:52:57.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
13,309 |
$88.70 |
$1,180,510.00 |
564,029 |
|
view |
S |
2021-06-14 |
2021-06-15 09:52:57.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
93,102 |
$87.75 |
$8,169,700.00 |
577,338 |
|
view |
S |
2021-06-14 |
2021-06-15 09:52:57.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
47,422 |
$86.73 |
$4,112,910.00 |
670,440 |
|
view |
S |
2021-06-14 |
2021-06-15 09:52:57.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
16,293 |
$85.92 |
$1,399,890.00 |
717,862 |
|
view |
S |
2021-06-11 |
2021-06-15 09:52:57.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
1,875 |
$85.98 |
$161,212.00 |
734,155 |
|
view |
S |
2021-06-11 |
2021-06-15 09:52:56.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
29,071 |
$85.18 |
$2,476,270.00 |
736,030 |
|
view |
S |
2021-04-29 |
2021-04-30 20:55:41.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
4,513 |
$85.43 |
$385,546.00 |
765,101 |
|
view |
S |
2021-04-28 |
2021-04-28 19:52:23.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
29,740 |
$86.12 |
$2,561,210.00 |
769,614 |
|
view |
S |
2021-04-28 |
2021-04-28 19:52:23.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
102,186 |
$85.40 |
$8,726,680.00 |
799,354 |
|
view |
S |
2021-04-27 |
2021-04-28 19:52:23.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
61,680 |
$87.08 |
$5,371,090.00 |
901,540 |
|
view |
S |
2021-04-27 |
2021-04-28 19:52:23.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
68,836 |
$86.41 |
$5,948,120.00 |
963,220 |
|
view |
S |
2021-04-27 |
2021-04-28 19:52:23.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
79,714 |
$85.39 |
$6,806,780.00 |
1,032,060 |
|
view |
S |
2021-04-26 |
2021-04-28 19:52:23.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
eight hundred and six |
$84.93 |
$68,453.60 |
1,111,770 |
|
view |
S |
2021-04-05 |
2021-04-07 14:15:11.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
eight hundred |
$84.98 |
$67,984.00 |
1,112,580 |
|
view |
S |
2021-04-05 |
2021-04-06 18:10:46.0 |
Intellia Therapeutics, Inc. |
NTLA |
DORSA CAROLINE |
director |
eight hundred |
$82.99 |
$66,392.00 |
5,410 |
|
view |
S |
2021-04-05 |
2021-04-06 18:10:46.0 |
Intellia Therapeutics, Inc. |
NTLA |
DORSA CAROLINE |
director |
4,686 |
$82.35 |
$385,892.00 |
6,210 |
|
view |
S |
2021-04-05 |
2021-04-06 18:10:46.0 |
Intellia Therapeutics, Inc. |
NTLA |
DORSA CAROLINE |
director |
2,014 |
$81.49 |
$164,121.00 |
10,896 |
|
view |
S |
2021-04-01 |
2021-04-02 20:47:16.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
13,895 |
$83.00 |
$1,153,280.00 |
693,368 |
|
view |
S |
2021-04-01 |
2021-04-02 20:47:16.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
24,314 |
$84.00 |
$2,042,380.00 |
681,222 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
one hundred and twenty-four |
$85.76 |
$10,634.20 |
162,388 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
1,213 |
$84.73 |
$102,777.00 |
162,512 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
2,258 |
$83.85 |
$189,333.00 |
163,725 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
3,361 |
$82.77 |
$278,190.00 |
165,983 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
6,768 |
$81.87 |
$554,096.00 |
169,344 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
1,965 |
$80.85 |
$158,870.00 |
176,112 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
one hundred and twenty-three |
$85.14 |
$10,472.20 |
145,076 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
1,049 |
$83.98 |
$88,095.00 |
145,199 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
nine hundred and fifty-one |
$82.87 |
$78,809.40 |
146,248 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
2,644 |
$81.95 |
$216,676.00 |
147,199 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
seven hundred |
$80.73 |
$56,511.00 |
149,843 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
nine hundred and sixty-three |
$84.87 |
$81,729.80 |
140,543 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
1,724 |
$83.72 |
$144,333.00 |
141,506 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
2,728 |
$82.63 |
$225,415.00 |
143,230 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
4,818 |
$81.83 |
$394,257.00 |
145,958 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
1,256 |
$80.82 |
$101,510.00 |
150,776 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
1,067 |
$84.94 |
$90,631.00 |
131,032 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
3,234 |
$83.91 |
$271,365.00 |
132,099 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
3,233 |
$82.76 |
$267,563.00 |
135,333 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
8,266 |
$81.89 |
$676,903.00 |
138,566 |
|
view |
S |
2021-04-01 |
2021-04-02 20:42:37.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
2,010 |
$80.79 |
$162,388.00 |
146,832 |
|
view |
S |
2021-02-26 |
2021-03-01 14:00:21.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
501,945 |
$60.29 |
$3.02627E7 |
1,113,380 |
|
view |
S |
2021-02-09 |
2021-02-09 20:38:45.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
11,489 |
$75.00 |
$861,675.00 |
117,920 |
|
view |
S |
2021-02-09 |
2021-02-09 20:36:35.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
28,043 |
$75.00 |
$2,103,220.00 |
660,536 |
|
view |
S |
2021-02-05 |
2021-02-09 20:36:35.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
eight hundred and eighty-one |
$68.78 |
$60,595.20 |
631,861 |
|
view |
S |
2021-02-05 |
2021-02-09 20:36:35.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
14,018 |
$67.86 |
$951,262.00 |
632,742 |
|
view |
S |
2021-02-05 |
2021-02-09 20:36:35.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
8,043 |
$67.18 |
$540,329.00 |
646,760 |
|
view |
S |
2021-02-03 |
2021-02-03 21:40:17.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
36,858 |
$73.00 |
$2,690,630.00 |
614,803 |
|
view |
S |
2021-02-03 |
2021-02-03 21:40:17.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
30,998 |
$72.00 |
$2,231,860.00 |
584,601 |
|
view |
S |
2021-02-01 |
2021-02-03 21:40:17.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
5,475 |
$65.04 |
$356,094.00 |
565,599 |
|
view |
S |
2021-02-01 |
2021-02-03 21:40:17.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
16,640 |
$64.10 |
$1,066,620.00 |
571,074 |
|
view |
S |
2021-02-01 |
2021-02-03 21:40:17.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
11,100 |
$63.30 |
$702,630.00 |
587,714 |
|
view |
S |
2021-02-01 |
2021-02-03 21:40:17.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
3,260 |
$65.03 |
$211,998.00 |
538,814 |
|
view |
S |
2021-02-01 |
2021-02-03 21:40:17.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
9,432 |
$64.09 |
$604,497.00 |
542,074 |
|
view |
S |
2021-02-01 |
2021-02-03 21:40:17.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
6,448 |
$63.29 |
$408,094.00 |
551,506 |
|
view |
S |
2021-02-01 |
2021-02-03 21:40:17.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
six hundred and ninety-three |
$65.02 |
$45,058.90 |
527,954 |
|
view |
S |
2021-02-01 |
2021-02-03 21:40:17.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
3,497 |
$64.16 |
$224,368.00 |
528,647 |
|
view |
S |
2021-02-01 |
2021-02-03 21:40:17.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
1,709 |
$63.24 |
$108,077.00 |
532,144 |
|
view |
S |
2021-02-01 |
2021-02-03 21:40:17.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
8,827 |
$65.00 |
$573,755.00 |
523,853 |
|
view |
S |
2021-02-01 |
2021-02-03 21:40:17.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
26,058 |
$64.13 |
$1,671,100.00 |
532,680 |
|
view |
S |
2021-02-01 |
2021-02-03 21:40:17.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
16,750 |
$63.32 |
$1,060,610.00 |
558,738 |
|
view |
S |
2021-02-01 |
2021-02-03 21:38:38.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
seven hundred and fifty-five |
$65.07 |
$49,127.90 |
108,409 |
|
view |
S |
2021-02-01 |
2021-02-03 21:38:38.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
2,386 |
$64.18 |
$153,133.00 |
109,164 |
|
view |
S |
2021-02-01 |
2021-02-03 21:38:38.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
2,326 |
$63.44 |
$147,561.00 |
111,550 |
|
view |
S |
2021-02-01 |
2021-02-03 21:38:38.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
2,827 |
$65.05 |
$183,896.00 |
103,876 |
|
view |
S |
2021-02-01 |
2021-02-03 21:38:38.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
8,366 |
$64.16 |
$536,763.00 |
106,703 |
|
view |
S |
2021-02-01 |
2021-02-03 21:38:38.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
6,617 |
$63.34 |
$419,121.00 |
115,069 |
|
view |
S |
2021-02-01 |
2021-02-03 21:38:38.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
5,312 |
$65.01 |
$345,333.00 |
88,686 |
|
view |
S |
2021-02-01 |
2021-02-03 21:38:38.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
15,594 |
$64.11 |
$999,731.00 |
93,998 |
|
view |
S |
2021-02-01 |
2021-02-03 21:38:38.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
10,476 |
$63.31 |
$663,236.00 |
109,592 |
|
view |
S |
2021-01-05 |
2021-01-05 21:25:20.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
6,239 |
$55.86 |
$348,511.00 |
475,488 |
|
view |
S |
2021-01-05 |
2021-01-05 20:59:01.0 |
Intellia Therapeutics, Inc. |
NTLA |
SCHIERMEIER ANDREW |
officer (EVP, Chief Operating Officer) |
1,377 |
$55.86 |
$76,919.20 |
16,656 |
|
view |
S |
2021-01-05 |
2021-01-05 20:55:55.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
2,078 |
$55.86 |
$116,077.00 |
51,990 |
|
view |
S |
2020-12-17 |
2020-12-18 16:29:41.0 |
Intellia Therapeutics, Inc. |
NTLA |
KARSEN PERRY A |
director |
21,336 |
$54.33 |
$1,159,180.00 |
5,000 |
|
view |
S |
2020-12-17 |
2020-12-18 16:29:41.0 |
Intellia Therapeutics, Inc. |
NTLA |
KARSEN PERRY A |
director |
45,450 |
$53.69 |
$2,440,210.00 |
26,336 |
|
view |
S |
2020-12-17 |
2020-12-18 16:29:41.0 |
Intellia Therapeutics, Inc. |
NTLA |
KARSEN PERRY A |
director |
21,978 |
$52.52 |
$1,154,280.00 |
71,786 |
|
view |
S |
2020-12-01 |
2020-12-03 18:42:31.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
two hundred and fifty-seven |
$39.46 |
$10,141.20 |
48,708 |
|
view |
S |
2020-12-01 |
2020-12-03 18:42:31.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
1,522 |
$38.49 |
$58,581.80 |
48,965 |
|
view |
S |
2020-12-01 |
2020-12-03 18:42:31.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
1,585 |
$37.73 |
$59,802.10 |
50,487 |
|
view |
S |
2020-11-27 |
2020-11-27 21:01:29.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
20,000 |
$39.00 |
$780,000.00 |
467,352 |
|
view |
S |
2020-11-27 |
2020-11-27 21:01:28.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
15,000 |
$38.00 |
$570,000.00 |
467,352 |
|
view |
S |
2020-11-25 |
2020-11-25 20:02:45.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
50,000 |
$36.00 |
$1,800,000.00 |
467,352 |
|
view |
S |
2020-11-16 |
2020-11-18 19:56:59.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
20,000 |
$34.00 |
$680,000.00 |
467,352 |
|
view |
S |
2020-11-18 |
2020-11-18 19:55:46.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
six hundred and twenty-four |
$35.00 |
$21,840.00 |
47,072 |
|
view |
S |
2020-11-16 |
2020-11-18 19:55:46.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
four hundred and fourteen |
$35.00 |
$14,490.00 |
46,848 |
|
view |
S |
2020-11-16 |
2020-11-18 19:55:46.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
3,595 |
$34.51 |
$124,063.00 |
46,700 |
|
view |
S |
2020-11-16 |
2020-11-18 19:55:46.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
2,020 |
$33.75 |
$68,175.00 |
50,295 |
|
view |
S |
2020-11-04 |
2020-11-06 16:41:44.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
3,364 |
$28.00 |
$94,192.00 |
42,315 |
|
view |
S |
2020-11-04 |
2020-11-06 16:39:27.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
50,000 |
$26.00 |
$1,300,000.00 |
467,352 |
|
view |
S |
2020-10-15 |
2020-10-16 20:58:36.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
one hundred and fifty-six |
$24.55 |
$3,829.80 |
40,679 |
|
view |
S |
2020-10-15 |
2020-10-16 20:58:36.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
5,459 |
$24.19 |
$132,053.00 |
40,835 |
|
view |
S |
2020-10-07 |
2020-10-09 16:14:44.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M |
director officer (President and CEO) |
5,000 |
$21.83 |
$109,150.00 |
467,352 |
|
view |
S |
2020-09-15 |
2020-09-17 16:56:08.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
5,615 |
$21.04 |
$118,140.00 |
36,294 |
|
view |
S |
2020-08-18 |
2020-08-20 16:14:36.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
5,615 |
$21.00 |
$117,915.00 |
31,909 |
|
view |
S |
2020-08-06 |
2020-08-07 19:29:54.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M. |
director officer (President and CEO) |
5,000 |
$21.83 |
$109,150.00 |
467,352 |
|
view |
S |
2020-07-15 |
2020-07-17 16:21:34.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
5,615 |
$22.70 |
$127,460.00 |
27,524 |
|
view |
S |
2020-07-01 |
2020-07-02 16:11:16.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M. |
director officer (President and CEO) |
5,000 |
$21.83 |
$109,150.00 |
467,352 |
|
view |
S |
2020-06-16 |
2020-06-18 17:00:51.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
5,615 |
$21.00 |
$117,915.00 |
22,282 |
|
view |
S |
2020-06-03 |
2020-06-05 17:19:45.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M. |
director officer (President and CEO) |
5,000 |
$21.83 |
$109,150.00 |
467,352 |
|
view |
S |
2020-05-26 |
2020-05-28 17:24:31.0 |
Intellia Therapeutics, Inc. |
NTLA |
Rivera Jose E |
officer (EVP, General Counsel) |
5,615 |
$21.21 |
$119,094.00 |
280,107 |
|
view |
P |
2019-03-06 |
2019-03-12 16:39:56.0 |
Intellia Therapeutics, Inc. |
NTLA |
SCHIERMEIER ANDREW |
officer (EVP, Dev and Corp Strategy) |
4,250 |
$15.50 |
$65,875.00 |
7,500 |
|
view |
P |
2019-03-06 |
2019-03-12 16:39:56.0 |
Intellia Therapeutics, Inc. |
NTLA |
SCHIERMEIER ANDREW |
officer (EVP, Dev and Corp Strategy) |
3,250 |
$16.00 |
$52,000.00 |
3,250 |
|
view |
S |
2018-07-16 |
2018-07-18 08:41:20.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
1,402 |
$31.93 |
$44,762.40 |
zero |
|
view |
S |
2018-07-16 |
2018-07-18 08:41:20.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
5,284 |
$30.97 |
$163,635.00 |
1,402 |
|
view |
S |
2018-06-19 |
2018-06-20 12:04:19.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
1,400 |
$28.39 |
$39,746.00 |
zero |
|
view |
S |
2018-06-19 |
2018-06-20 12:04:19.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
5,286 |
$27.84 |
$147,162.00 |
1,400 |
|
view |
S |
2018-05-16 |
2018-05-17 10:47:39.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
6,686 |
$25.04 |
$167,389.00 |
zero |
|
view |
S |
2018-05-14 |
2018-05-15 20:43:58.0 |
Intellia Therapeutics, Inc. |
NTLA |
LEONARD JOHN M. |
director officer (President and CEO) |
8,400 |
$24.00 |
$201,600.00 |
zero |
|
view |
S |
2018-03-20 |
2018-03-22 13:44:09.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
36,628 |
$23.78 |
$871,160.00 |
zero |
|
view |
S |
2018-03-20 |
2018-03-22 13:44:09.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
2,617 |
$25.06 |
$65,582.30 |
36,628 |
|
view |
S |
2018-01-29 |
2018-01-30 17:29:24.0 |
Intellia Therapeutics, Inc. |
NTLA |
Caribou Biosciences, Inc. |
|
550,645 |
$26.78 |
$1.47463E7 |
3,994,360 |
|
view |
S |
2017-12-12 |
2017-12-14 12:19:45.0 |
Intellia Therapeutics, Inc. |
NTLA |
NOVARTIS AG |
various 10% owner |
1,523,000 |
$18.30 |
$2.78709E7 |
4,129,900 |
|
view |
S |
2017-12-08 |
2017-12-08 17:28:14.0 |
Intellia Therapeutics, Inc. |
NTLA |
Bermingham Nessan |
director officer (President & CEO) |
94,143 |
$20.82 |
$1,960,150.00 |
458,250 |
|
view |
S |
2017-12-07 |
2017-12-08 17:28:14.0 |
Intellia Therapeutics, Inc. |
NTLA |
Bermingham Nessan |
director officer (President & CEO) |
27,566 |
$21.46 |
$591,489.00 |
552,393 |
|
view |
S |
2017-12-07 |
2017-12-08 17:28:14.0 |
Intellia Therapeutics, Inc. |
NTLA |
Bermingham Nessan |
director officer (President & CEO) |
103,574 |
$21.05 |
$2,180,380.00 |
579,959 |
|
view |
S |
2017-12-06 |
2017-12-08 17:28:14.0 |
Intellia Therapeutics, Inc. |
NTLA |
Bermingham Nessan |
director officer (President & CEO) |
12,467 |
$20.84 |
$259,810.00 |
683,533 |
|
view |
S |
2017-12-06 |
2017-12-08 17:28:14.0 |
Intellia Therapeutics, Inc. |
NTLA |
Bermingham Nessan |
director officer (President & CEO) |
99,033 |
$20.28 |
$2,008,190.00 |
696,000 |
|
view |
S |
2017-09-13 |
2017-09-13 18:30:30.0 |
Intellia Therapeutics, Inc. |
NTLA |
Caribou Biosciences, Inc. |
|
1,048,850 |
$0.00 |
$0.00 |
4,545,000 |
|
view |
S |
2017-07-11 |
2017-07-11 17:41:00.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
80,000 |
$16.07 |
$1,285,560.00 |
3,579,790 |
|
view |
S |
2017-07-10 |
2017-07-11 17:41:00.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
40,000 |
$16.17 |
$646,888.00 |
3,659,790 |
|
view |
S |
2017-07-07 |
2017-07-11 17:41:00.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
30,000 |
$16.77 |
$502,992.00 |
3,699,790 |
|
view |
S |
2017-07-11 |
2017-07-11 17:37:41.0 |
Intellia Therapeutics, Inc. |
NTLA |
Atlas Venture Associates IX, LLC |
various various 10% owner |
80,000 |
$16.07 |
$1,285,560.00 |
3,579,790 |
|
view |
S |
2017-07-10 |
2017-07-11 17:37:41.0 |
Intellia Therapeutics, Inc. |
NTLA |
Atlas Venture Associates IX, LLC |
various various 10% owner |
40,000 |
$16.17 |
$646,888.00 |
3,659,790 |
|
view |
S |
2017-07-07 |
2017-07-11 17:37:41.0 |
Intellia Therapeutics, Inc. |
NTLA |
Atlas Venture Associates IX, LLC |
various various 10% owner |
30,000 |
$16.77 |
$502,992.00 |
3,699,790 |
|
view |
S |
2017-03-10 |
2017-03-13 10:39:52.0 |
Intellia Therapeutics, Inc. |
NTLA |
Atlas Venture Associates IX, L |
various 10% owner |
5,504 |
$14.06 |
$77,410.50 |
zero |
N/A |
view |
S |
2017-03-09 |
2017-03-13 10:39:52.0 |
Intellia Therapeutics, Inc. |
NTLA |
Atlas Venture Associates IX, L |
various 10% owner |
15,628 |
$13.85 |
$216,432.00 |
5,504 |
N/A |
view |
S |
2017-03-10 |
2017-03-13 10:35:01.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
5,504 |
$14.06 |
$77,410.50 |
zero |
N/A |
view |
S |
2017-03-09 |
2017-03-13 10:35:01.0 |
Intellia Therapeutics, Inc. |
NTLA |
FORMELA JEAN FRANCOIS |
director |
15,628 |
$13.85 |
$216,432.00 |
5,504 |
N/A |
view |
P* |
2016-05-11 |
2016-05-13 17:11:05.0 |
Intellia Therapeutics, Inc. |
NTLA |
ISALY SAMUEL D |
various various various director |
58,534 |
$18.00 |
$1,053,610.00 |
2,662,180 |
N/A |
view |
P* |
2016-05-11 |
2016-05-13 17:11:05.0 |
Intellia Therapeutics, Inc. |
NTLA |
ISALY SAMUEL D |
various various various director |
191,466 |
$18.00 |
$3,446,390.00 |
2,603,650 |
N/A |
view |
P* |
2016-05-11 |
2016-05-13 08:00:12.0 |
Intellia Therapeutics, Inc. |
NTLA |
TLS Beta Pte. Ltd. |
various various various 10% owner |
300,000 |
$18.00 |
$5,400,000.00 |
790,527 |
N/A |
view |
P |
2016-05-11 |
2016-05-11 18:59:05.0 |
Intellia Therapeutics, Inc. |
NTLA |
NOVARTIS AG |
various 10% owner |
277,777 |
$18.00 |
$4,999,990.00 |
5,573,660 |
N/A |
view |
P |
2016-05-11 |
2016-05-11 18:44:06.0 |
Intellia Therapeutics, Inc. |
NTLA |
GORDON CARL L |
director |
58,534 |
$18.00 |
$1,053,610.00 |
2,662,180 |
N/A |
view |
P |
2016-05-11 |
2016-05-11 18:44:06.0 |
Intellia Therapeutics, Inc. |
NTLA |
GORDON CARL L |
director |
191,466 |
$18.00 |
$3,446,390.00 |
2,603,650 |
N/A |
view |
P |
2016-05-11 |
2016-05-11 16:26:35.0 |
Intellia Therapeutics, Inc. |
NTLA |
Baker Bros. Advisors (GP) LLC |
various various various other |
179,531 |
$18.00 |
$3,231,560.00 |
976,214 |
N/A |
view |
P |
2016-05-11 |
2016-05-11 16:26:35.0 |
Intellia Therapeutics, Inc. |
NTLA |
Baker Bros. Advisors (GP) LLC |
various various various other |
20,469 |
$18.00 |
$368,442.00 |
85,906 |
N/A |
view |